SCHEMBL1807903

SCHEMBL1807903

CCOc1cc2c(NCc3cc(S(N)(=O)=O)ccc3OCC(F)(F)F)ncnc2cc1OC

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BRAF P15056 3/20 0.63
TNNI3K Q59H18 3/20 0.63
MAPK1 P28482 2/20 0.49
EGFR P00533 7/20 0.48
ALDH1A1 P00352 3/20 0.48
HTT P42858 3/20 0.48
ERBB2 P04626 2/20 0.48
HPGD P15428 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 3/20 0.47
ENPP1 P22413 3/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
LMNA P02545 1/20 0.46
LCK P06239 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1805724 1.00 BRAF (0.63) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1806484 0.97 TNNI3K (0.58) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1806158 0.96 BRAF (0.61) BRAFTNNI3KMAPK1EGFRALDH1A1
Hydrochloric Acid SCHEMBL1804510 0.95 BRAF (0.60) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1804741 0.92 BRAF (0.55) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1806081 0.90 BRAF (0.64) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1805541 0.90 BRAF (0.54) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1808229 0.89 BRAF (0.53) BRAFTNNI3KMAPK1EGFRALDH1A1
SCHEMBL1806487 0.89 BRAF (0.51) BRAFTNNI3KMAPK1EGFRKMT2A
SCHEMBL1806390 0.86 MAPK1 (0.54) BRAFTNNI3KMAPK1EGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP claimed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO claimed
EP-2501233-A1 QUINAZOLINE COMPOUNDS GlaxoSmithKline LLC (US) 2012-09-26 EP disclosed
WO-2011056740-A1 QUINAZOLINE COMPOUNDS GLAXOSMITHKLINE LLC (US) 2011-05-12 WO disclosed